Antagonists Induce a Conformational Change in clAP1 That Promotes AutoubiquitinationDUEBER, Erin C; SCHOEFFLER, Allyn J; WALLWEBER, Heidi J. A et al.Science (Washington, D.C.). 2011, Vol 334, Num 6054, pp 376-380, issn 0036-8075, 5 p.Article

International symposium on ion channels and calcium antagonistsZhōngguó yàoli xuébào. 1992, Vol 13, Num 1, issn 0253-9756, 72 p.Conference Paper

Generation of a Specific Activin Antagonist by Modification of the Activin A PropeptideMAKANJI, Yogeshwar; WALTON, Kelly L; CHAN, Karen L et al.Endocrinology (Philadelphia). 2011, Vol 152, Num 10, pp 3758-3768, issn 0013-7227, 11 p.Article

Aquatic Antagonists: Cubozoan Jellyfish (Chironex fleckeri and Carukia barnesi)OTTUSO, Patrick Thomas.Cutis (New York, NY). 2010, Vol 85, Num 3, pp 133-136, issn 0011-4162, 4 p.Article

Aquatic Antagonists: Bluegill (Lepomis macrochirus)RANARIO, Jennifer S; WIRGES, Marla L; SMITH, Jennifer L et al.Cutis (New York, NY). 2012, Vol 90, Num 5, pp 222-223, issn 0011-4162, 2 p.Article

Aquatic Antagonists: How to Surgically Remove a FishhookROSSY, Kathleen M; LAWRENCE, Naomi.Cutis (New York, NY). 2011, Vol 88, Num 1, pp 11-12, issn 0011-4162, 2 p.Article

Cadiac mass and aortic distensibility following calcium blockade in hypertensionSAFAR, M. E; PANNIER, B. P; LACOLLEY, P. J et al.Journal of cardiovascular pharmacology. 1991, Vol 17, pp S75-S80, issn 0160-2446, SUP2Conference Paper

Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brainARNT, J; CHRISTENSEN, A. V; HYTTEL, J et al.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 329, Num 2, pp 101-107, issn 0028-1298Article

Drug inhibition of mast cell secretionLUDOWYKE, R; LAGUNOFF, D.Progress in drug research. 1985, Vol 29, pp 277-301, issn 0071-786XArticle

Opioid AntagonistsBARNETT, Victoria; TWYCROSS, Robert; MIHALYO, Mary et al.Journal of pain and symptom management. 2014, Vol 47, Num 2, pp 341-352, issn 0885-3924, 12 p.Article

Effect of flunarizine on micro-regional distributions of intravascular HbO₂ saturations in RiF-1 and KHT sarcomasFENTON, B. M; SUTHERLAND, R. M.International journal of radiation oncology, biology, physics. 1992, Vol 22, Num 3, pp 447-450, issn 0360-3016Conference Paper

Anti-ischemic and membrane stabilizing activity of calmodulin inhibitorsBERESEWICZ, A.Basic research in cardiology. 1989, Vol 84, Num 6, pp 631-645, issn 0300-8428, 15 p.Article

Inhibition de la dégranulation des basophiles humains par les inhibiteurs calciques = Inhibition of degranulation of the human basophils by the calcium antagonistsFRISCH, C; LEYNADIER, F; NASSAR, A et al.Journal de pharmacologie. 1985, Vol 16, Num 4, pp 381-390, issn 0021-793XArticle

Interactions between a calcium channel agonist, Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K⁺-depolarized smooth muscleSPEDDING, M; BERG, C.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 328, Num 1, pp 69-75, issn 0028-1298Article

Interactions between the putative calcium entry promotor Bay k 8644 and pressor responses produced by α₁- and α₂-adrenoceptor agonists in the pithed normotensive ratWILFERT, B; VAN HEININGEN, P. N. M; MATHY, M. J et al.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 328, Num 1, pp 76-82, issn 0028-1298Article

Direct agonist/antagonist functions of dehydroepiandrosteroneFANG CHEN; KNECHT, Kristin; RESZKA, Alfred A et al.Endocrinology (Philadelphia). 2005, Vol 146, Num 11, pp 4568-4576, issn 0013-7227, 9 p.Article

An HPLC method for determination of atropine in human plasmaSHAOYOUG LI; WAHBA KHALIL, S. K.Journal of liquid chromatography. 1990, Vol 13, Num 7, pp 1339-1350, issn 0148-3919Article

L'isoflurane est-il un antagoniste du calcium? = Is isoflurane a calcium antagonist?BLAISE, G. A; GIRARD, D. C; CAILLE, G et al.Annales françaises d'anesthésie et de réanimation. 1989, Vol 8, Num 1, pp 42-45, issn 0750-7658Article

Actualités en pharmacovigilance = Actualities in drug monitoringLAGIER, G; DE CREMOUX, P.Concours médical (Paris). 1989, Vol 111, Num 16, pp 1347-1354, issn 0010-5309, 6 p.Article

Proceedings/International symposium on flumazenil, the first benzodiazepine antagonist, Geneva, Switzerland, February 1988GELLER, E; THOMSON, D.European journal of anaesthesiology. 1988, issn 0265-0215, 332 p., suppl. 2Conference Proceedings

Accidents vasculaires cérébraux et décès sous olanzapine = Cerebrovascular adverse events and death under olanzapineLa Revue Prescrire. 2004, Vol 24, Num 250, issn 0247-7750, p. 349Article

Switching from depot antipsychotic drugs to olanzapine in Patients with chronic schizophreniaGODLESKI, Linda S; GOLDSMITH, L. Jane; VIEWEG, W. Victor et al.The Journal of clinical psychiatry. 2003, Vol 64, Num 2, pp 119-122, issn 0160-6689, 4 p.Article

Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disordersBREIER, A; SU, T.-P; MALHOTRA, A. K et al.Neuropsychopharmacology (New York, NY). 1999, Vol 20, Num 4, pp 340-345, issn 0893-133XArticle

Proceedings/Calcium antagonists: pharmacology and clinical research, conference, February 10-13, 1987, New York, NYVANHOUTTE, P. M; APOLETTI, R; GOVONI, S et al.Annals of the New York Academy of Sciences. 1988, Vol 522, issn 0077-8923, 803 p.Conference Proceedings

Progress in modern psychopharmacology: clinical experience with risperidone long-acting injectable in Schizophrenia and Schizoaffective disordersDURSUN, Serdar.Journal of psychopharmacology (Oxford). 2005, Vol 19, Num 5, issn 0269-8811, 37 p., SUPSerial Issue